Indeterminate cell histiocytosis treated with 0.5% delgocitinib ointment

descriptionPublicationkeyboard_double_arrow_right Article 08 Feb 2023 English Publisher:Oxford University Press (OUP)Journal:British Journal of Dermatology, volume 188, pages e39-e39 (issn: 0007-0963, eissn: 1365-2133,

Authors: Rai F T, Fujimoto; Hiroyuki, Miura; Mayumi, Takata; Sakukei, Fujiwara;

doi: 10.1093/bjd/ljad029

pmid: 36753385

Indeterminate cell histiocytosis treated with 0.5% delgocitinib ointment

- Summary
- Subjects
- Metrics

Abstract

Although delgocitinib has been used for atopic dermatitis, it is also effective for indeterminate cell histiocytosis, a rare CD207–/CD1a+ histiocyte proliferative disease.

Keywords

Ointments, Humans, Pyrroles, Histiocytosis

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average